Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

Proteome Analysis

Below the proteome analysis is presented. The analysis methods are presented in the paper Propagating Differential Gene Expression in Protein Interaction Networks. If you are interested in the most reliable results choose the

  • value_type as 'ranked' since this provides a very robust analysis method.
  • intercation map as 'high confidence'
  • network_comparison type as 'Divided' since this leads to a natural grouping of similar proteins
  • filtered as 'true' since this will only use the microarray measurements that have a sufficiently large confidence level.

  • Navigation/Query Panel:
    Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
    description Rank Gene Hugo Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
    Results: HTML CSV LaTeX Showing element 830 to 879 of 6456 in total
    Value Type  : Ranked
    Interaction Map  : High confidence
    Filtered  : 1
    description
    Rank
    Hugo
    Network Comparison Type
    red
    green
    network_comparison
    bifunctional purine biosynthesis protein purh [includes: phosphoribosylaminoimidazolecarboxamide formyltransferase (ec 2.1.2.3) (aicar transformylase); imp cyclohydrolase (ec 3.5.4.10) (inosinicase) (imp synthetase) (atic)]. [swissprot;acc:p31939] 740 ATIC Divided 223.58 235.027 1.0512
    bile acid coenzyme a: amino acid n-acyltransferase; glycine n-choloyltransferase. [refseq;acc:nm_001701] 1836 BAAT Subtracted 218.441 216.064 2.377
    1848 Divided 1.011
    biotin--protein ligase (ec 6.3.4.-) (biotin apo-protein ligase) [includes: biotin--[methylmalonyl-coa-carboxyltransferase] ligase (ec 6.3.4.9); biotin--[propionyl-coa-carboxylase [atp-hydrolyzing]] ligase (ec 6.3.4.10) (holocarboxylase synthetase) (hcs); biotin--[methylcrotonoyl-coa-carboxylase] ligase (ec 6.3.4.11); biotin--[acetyl-coa-carboxylase] ligase (ec 6.3.4.15)]. [swissprot;acc:p50747] 1699 HLCS Subtracted 218.436 215.553 2.883
    1711 Divided 1.01337
    block 23. [sptrembl;acc:q8nhw5] 1021 no value Subtracted 226.205 232.858 6.653
    1091 Divided 1.02941
    block of proliferation 1. [swissprot;acc:q14137] 438 BOP1 Subtracted 250.794 234.433 16.361
    512 Divided 1.06979
    blood group rh(ce) polypeptide (rhesus c/e antigens) (rh30a) (rhixb) (rh polypeptide 1) (rhpi). [swissprot;acc:p18577] 1930 no value 196.964 198.935 1.01001
    1932 196.965 198.936
    1987 Subtracted 196.964 198.935 1.971
    1988 196.965 198.936
    blood group rh(d) polypeptide (rhesus d antigen) (rhxiii) (rh polypeptide 2) (rhpii). [swissprot;acc:q02161] 1928 RHD Divided 196.964 198.935 1.01001
    1986 Subtracted 1.971
    bloom's syndrome protein (ec 3.6.1.-) (recq protein-like 3) (dna helicase, recq-like, type 2). [swissprot;acc:p54132] 1748 no value Divided 215.673 212.971 1.01269
    1756 Subtracted 2.702
    bomapin (protease inhibitor 10) (serpin b10). [swissprot;acc:p48595] 759 SERPINB10 224.244 234.511 10.267
    793 Divided 1.04578
    bone morphogenetic protein 5 precursor (bmp-5). [swissprot;acc:p22003] 3069 BMP5 0.00001 0.00001 1
    Subtracted 0 0 0
    bone morphogenetic protein 6 precursor (bmp-6). [swissprot;acc:p22004] 2896 BMP6 Divided 0.00001 0.00001 1
    Subtracted 0 0 0
    bone morphogenetic protein 7 precursor (bmp-7) (osteogenic protein 1) (op-1). [swissprot;acc:p18075] 3128 BMP7 Divided 0.00001 0.00001 1
    Subtracted 0 0 0
    bone morphogenetic protein 8 precursor (bmp-8) (osteogenic protein 2) (op-2). [swissprot;acc:p34820] 2773 BMP8A Divided 0.00001 0.00001 1
    Subtracted 0 0 0
    brachyury protein (t protein). [swissprot;acc:o15178] 2040 T Divided 210.586 208.803 1.00854
    2043 Subtracted 1.783
    brain protein 16. [refseq;acc:nm_016458] 1835 no value 216.811 219.195 2.384
    1847 Divided 1.011
    brain protein 44. [swissprot;acc:o95563] 742 BRP44 126.215 120.078 1.05111
    1062 Subtracted 6.137
    branched-chain amino acid aminotransferase, cytosolic (ec 2.6.1.42) (bcat(c)) (eca39 protein). [swissprot;acc:p54687] 2672 BCAT1 Divided 210.957 210.741 1.00102
    Subtracted 0.216
    branched-chain amino acid aminotransferase, mitochondrial precursor (ec 2.6.1.42) (bcat(m)) (placental protein 18) (pp18). [swissprot;acc:o15382] 2681 BCAT2 210.939 210.755 0.184
    2687 Divided 1.00087
    brca1 associated protein. [refseq;acc:nm_006768] 3161 BRAP 0.00001 0.00001 1
    Subtracted 0 0 0
    brca1-associated ring domain protein 1 (bard-1). [swissprot;acc:q99728] 1745 BARD1 216.271 218.991 2.72
    1752 Divided 1.01258
    brca2 and cdkn1a-interacting protein isoform bccipalpha; brca2 and cdkn1a-interacting protein; cdk inhibitor p21 binding protein; bccipalpha; bccipbeta; tok-1alpha; tok-1beta. [refseq;acc:nm_016567] 209 BCCIP Subtracted 240.782 265.717 24.935
    294 Divided 1.10356
    breast cancer antiestrogen resistance 3. [refseq;acc:nm_003567] 229 BCAR3 226.401 202.094 1.12028
    232 Subtracted 24.307
    breast cancer type 1 susceptibility protein. [swissprot;acc:p38398] 920 BRCA1 216.501 224.27 7.769
    939 Divided 1.03588
    breast carcinoma amplified sequence 2; spliceosome associated protein, amplified in breast cancer. [refseq;acc:nm_005872] 691 BCAS2 217.602 206.195 1.05532
    693 Subtracted 11.407
    brefeldin a-inhibited guanine nucleotide-exchange protein 1 (brefeldin a-inhibited gep 1) (p200 arf-gep1) (p200 arf guanine nucleotide exchange factor). [swissprot;acc:q9y6d6] 2705 ARFGEF1 220.521 220.395 0.126

    Legend:
    - Rank is the rank after comparing the two networks
    - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
    - Hugo is the HGNC identifier if it exists
    - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
    - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
    - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
    - Filtered specifies whether we only included the high confidence microarry measurements or not.

    - http://analysis.yellowcouch.org/